iRhythm Holdings (IRTC) Change in Accured Expenses (2015 - 2023)
iRhythm Holdings' (IRTC) quarterly Change in Accured Expenses came in at $8.4 million in Q4 2023, up 31.04% year-on-year from $6.4 million in Q4 2022, and down 31.13% on a QoQ basis from $12.2 million in Q3 2023.
iRhythm Holdings (IRTC) Change in Accured Expenses (2015 - 2023) Analysis & Trends
iRhythm Holdings (IRTC) has 9 years of Change in Accured Expenses data on file, last reported at $8.4 million in Q4 2023.
- On a quarterly basis, Change in Accured Expenses rose 31.04% year-over-year to $8.4 million in Q4 2023; TTM through Dec 2023 was $19.3 million, a 33.34% increase from a year earlier, with the FY2023 full-year figure at $19.3 million, up 33.34% from the prior year.
- Change in Accured Expenses for Q4 2023 stood at $8.4 million, down from $12.2 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for IRTC reached as high as $13.3 million in Q3 2021 and fell as low as -$11.2 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of $4.2 million in 2020.
- On a YoY basis, Change in Accured Expenses climbed as much as 1971.62% in 2021 and fell as far as 150.83% in 2021.
- Year by year, Change in Accured Expenses stood at $367000.0 in 2019, then surged by 1718.26% to $6.7 million in 2020, then slumped by 150.83% to -$3.4 million in 2021, then jumped by 288.71% to $6.4 million in 2022, then soared by 31.04% to $8.4 million in 2023.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $8.4 million in Q4 2023, $12.2 million in Q3 2023, and $10.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 21.07 Mn |
| 10 | iRhythm Holdings | 3.67 Bn | 3.12 Bn | 141.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8.39 Mn |
| Dec 31, 2023 | 8.39 Mn |
| Sep 30, 2023 | 12.18 Mn |
| Sep 30, 2023 | 12.18 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Mar 31, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.23 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Sep 30, 2022 | 9.35 Mn |
| Sep 30, 2022 | 9.35 Mn |
| Jun 30, 2022 | 8.15 Mn |
| Jun 30, 2022 | 8.15 Mn |
| Mar 31, 2022 | -9.43 Mn |
| Mar 31, 2022 | -9.43 Mn |
| Dec 31, 2021 | -3.39 Mn |
| Dec 31, 2021 | -3.39 Mn |
| Sep 30, 2021 | 13.32 Mn |
| Sep 30, 2021 | 13.32 Mn |